The invention relates to hESF I, II and III polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

 
Web www.patentalert.com

< Fluorescent proteins

< IL-3 variant hematopoiesis fusion protein

> Fusion protein having enhanced in vivo erythropoietin activity

> Cloning and characterization of a CD2 binding protein (CD2BP2)

~ 00282